Omicron:increased transmissibility and decreased pathogenicity  

作　　者：Gábor Bálint Barbara Vörös-Horváth Aleksandar Széchenyi 

机构地区：[1]Institute of Pharmaceutical Technology and Biopharmacy,University of Pécs,Faculty of Pharmacy,7624 Pécs,Rókus u.2,Pécs,Hungary

出　　处：《Signal Transduction and Targeted Therapy》2022年第6期1865-1867,共3页信号转导与靶向治疗（英文）

摘　　要：Three research papers were published recently to compare the virological properties of the Omicron variant with the earlier variants of concern(VOC).1,2,3 The SARS-CoV-2 B.1.1.529 variant,Omicron,was first detected in South Africa in October 2021 and has spread rapidly;within three months,it appeared in more than 87 countries.4 During the surveillance of the epidemiological data and mutations of earlier COVID-19 variants and Omicron,significant differences were revealed mainly in the reproduction rate and hospitalization.

关 键 词：OMI EARLIER REPRODUCTION 

分 类 号：R563.1[医药卫生—呼吸系统]